Eric Weisblum insider trades
Open-market stock purchases and sales by Eric Weisblum, Chief Executive Officer at Silo Pharma, Inc, from SEC Form 4 filings since Jun 20, 2013.
Track record: 100% of 16 scored buys are up 5% or more since purchase, averaging +214%.